- Home
- SNBR vs BDTX Comparison
SNBR vs BDTX Comparison
Compare SNBR & BDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SNBR | BDTX |
|---|---|---|
| Founded | 1987 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Home Furnishings | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 186.9M | 148.1M |
| IPO Year | 1998 | 2020 |
Fundamental Metrics
Financial Performance| Metric | SNBR | BDTX |
|---|---|---|
| Price | $8.45 | $2.46 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 6 |
| Target Price | $8.00 | ★ $10.60 |
| AVG Volume (30 Days) | 680.9K | ★ 1.6M |
| Earning Date | 11-05-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.38 |
| Revenue | ★ $1,440,882,000.00 | $70,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $6.43 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.49 | $1.20 |
| 52 Week High | $19.13 | $4.94 |
Technical Indicators
Market Signals| Indicator | SNBR | BDTX |
|---|---|---|
| Relative Strength Index (RSI) | 67.24 | 31.10 |
| Support Level | $8.17 | $2.52 |
| Resistance Level | $8.85 | $2.69 |
| Average True Range (ATR) | 0.57 | 0.12 |
| MACD | -0.06 | 0.02 |
| Stochastic Oscillator | 64.39 | 7.32 |
Price Performance
Historical ComparisonAbout SNBR Sleep Number Corporation
Sleep Number Corp. is a wellness technology company engaged in the design, manufacturing, marketing and distribution of sleep solutions. The Company generates revenue by marketing and selling its smart beds directly to new and existing customers through its vertically integrated, exclusive, direct-to-consumer retail touch points including Stores, Online, Phone, and Chat (Total Retail). The products offered by the company are Mattresses, Bedding, Pillows and Furniture.
About BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.